<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To investigate the effect of bevacizumab on <z:hpo ids='HP_0011505'>cystoid macular edema</z:hpo> in <z:chebi fb="6" ids="22696">Beh</z:chebi>çet disease </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Twelve eyes of 11 patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet disease underwent optical coherence tomography, <z:chebi fb="0" ids="31624">fluorescein</z:chebi> angiography, and visual acuity measurement before and after the intravitreal injection of Avastin to evaluate its effect </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: The visual acuity improved in 7 eyes </plain></SENT>
<SENT sid="3" pm="."><plain>Foveal thickness and macular volume did not show statistically significant differences </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="31624">Fluorescein</z:chebi> angiography reduced in grading in 4 patients and was deteriorated in 2 </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: The intravitreal injection of Avastin could be effective in the improvement of the vision in patients with <z:hpo ids='HP_0000554'>uveitis</z:hpo> secondary to <z:chebi fb="6" ids="22696">Beh</z:chebi>çet disease </plain></SENT>
</text></document>